Agoracom Blog Home

Archive for the ‘Featured’ Category

« Older Entries
Newer Entries »

INTERVIEW: Tetra Bio-Pharma $TBP.ca Discusses Clinical Study for Smoked #Marijuana #CBD #MMJ $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 8:21 AM on Friday, November 17th, 2017

Tetra Bio-Pharma is no ordinary Medical Cannabis company. As a true Cannabis Bio-Pharma company, the company is the FIRST and ONLY pharmaceutical company in clinical trials for smoked marijuana, which is currently set to enter the valuable Phase 3 part of the trial.

AGORACOM Sat Down With President, Bernard Fortier To Discuss The Following:

1. How conducting clinical trials is massive differentiator from other companies.
2. The duration of Phase 3
3. The size of the market that will be available upon successful completion of Phase 3
4. How a successful Phase 3 can help solve the opioid crisis
5. Why the Company believes its’ inhalation device will generate $1.5M in revenue for Fiscal 2018
6. The Company’s distribution partnership with Aphria
7. Where the Medical Cannabis industry will be within 5 years

Tags: , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, Featured, Tetra Bio-Pharma Inc. | Comments Off on INTERVIEW: Tetra Bio-Pharma $TBP.ca Discusses Clinical Study for Smoked #Marijuana #CBD #MMJ $AERO $CBDS $CGRW $APH.ca $GBLX

Successful Program on Seabridge’s $SA $SEA.ca Iron Cap Has Significant Implications For Both The KSM and Treaty Creek $SKE.ca $TUD.ca $PVG

Posted by AGORACOM-JC at 10:56 AM on Thursday, November 16th, 2017

Hublogolarge2 copy

  • Seabridge Gold just concluded a very successful program on their Iron Cap zone (bordering Treaty Creek) which confirms the report to be correct
  • Report predicted that the Iron Cap could be one of “B.C.’s next big deposits” and the recently concluded 2017 exploration program confirms that it is

November 16, 2017 

TSX-V:AMK

Cardston, Alberta

In 2014 a significant geological report (Kyba / Nelson) was published with a new geological understanding concerning the “mega deposits” found in B.C.’s Golden Triangle.  Seabridge Gold just concluded a very successful program on their Iron Cap zone (bordering Treaty Creek) which confirms the report to be correct.  The report predicted that the Iron Cap could be one of “B.C.’s next big deposits” and the recently concluded 2017 exploration program confirms that it is.  The report also predicted that Treaty Creek could be one of “B.C.’s next big deposits” and the 2017 exploration program initial results are confirming that is the case.  Co-author Jeff Kyba has left his position as Regional Geologist for the B.C. Ministry of Energy and Mines (Skeena division) and is now assisting in advancing Treaty Creek.

See how the successful Iron Cap program has significant implications for both the KSM and the Treaty Creek projects.

CLICK HERE

 

A summary of the Treaty Creek project can be viewed here: http://www.americancreek.com/images/pdf/Treaty_Creek_Joint_Venture_Project.pdf

The Treaty Creek Project is a joint venture between Tudor, Teuton Resources Corp., and American Creek. Tudor is the operator and holds a 60% interest with both American Creek and Teuton each holding respective 20% carried interests in the property (fully carried until a production notice is given).

About American Creek

American Creek holds a strong portfolio of gold and silver properties in British Columbia. The portfolio includes three “Golden Triangle” gold/silver properties; the Treaty Creek and Electrum joint ventures with Walter Storm/Tudor as well as the recently acquired 100% owned past producing Dunwell Mine group of properties. Other properties held throughout BC include the Gold Hill, Austruck-Bonanza, Ample Goldmax, Silver Side, and Glitter King.

For further information please contact Kelvin Burton at: Phone: 403 752-4040 or Email: [email protected]. Information relating to the Corporation is available on its website at www.americancreek.com

Tags: , , , ,
Posted in All Recent Posts, American Creek Resources Ltd., Featured | Comments Off on Successful Program on Seabridge’s $SA $SEA.ca Iron Cap Has Significant Implications For Both The KSM and Treaty Creek $SKE.ca $TUD.ca $PVG

ThreeD Capital Inc. $IDK.ca Acquires Securities of Global Cannabis Applications Corp. $APP.ca $PNP.ca $ZC.ca

Posted by AGORACOM-JC at 10:13 AM on Thursday, November 16th, 2017

Threed capital

  • Acquired ownership and control of an aggregate of 2,000,000 common shares and 2,000,000 common share purchase warrants of Global Cannabis Applications Corp. 
  • Represented approximately 3.7% of all issued and outstanding common shares of Global Cannabis

TORONTO, Nov. 16, 2017 – ThreeD Capital Inc. ( “ThreeD”) (CSE:IDK) is pleased to announce that it has acquired ownership and control of an aggregate of 2,000,000 common shares (the “Subject Shares”) and 2,000,000 common share purchase warrants (the “Subject Warrants” and together with the Subject Shares, the “Subject Units”) of Global Cannabis Applications Corp. (“Global Cannabis”) on November 15, 2017.  The Subject Units represented approximately 3.7% of all issued and outstanding common shares of Global Cannabis as of November 15, 2017 immediately following the transaction described above (or approximately 7.2% on a partially diluted basis, assuming exercise of the Subject Warrants only), resulting in a corresponding increase in the percentage of shares held by ThreeD and its Joint Actor as a result of the transaction.

Immediately before the transaction described above, ThreeD and the Joint Actor held an aggregate of 2,850,000 common shares of the Company (the “Pre-Closing Shares”), representing approximately 5.5% of the issued and outstanding common shares of the Company.  Of this total, ThreeD held an aggregate of 1,000,000 of the Pre-Closing Shares (representing approximately 1.9% of the issued and outstanding common shares of the Company), and the Joint Actor held an aggregate of 1,850,000 of the Pre-Closing Shares (representing approximately 3.6% of the issued and outstanding common shares of the Company).

Immediately following the transaction described above, ThreeD and the Joint Actor held an aggregate of 4,850,000 common shares (the “Post-Closing Shares”) and convertible securities entitling ThreeD and the Joint Actor to acquire an additional 2,000,000 common shares of the Company (the “Post-Closing Convertible Securities”), representing approximately 9.0% of the issued and outstanding common shares of the Company (or approximately 12.3% assuming exercise of such Post-Closing Convertible Securities only).  Of this total, ThreeD held an aggregate of 3,000,000 of the Post-Closing Shares and 2,000,000 of the Post-Closing Convertible Securities (representing approximately 5.6% of the issued and outstanding common shares of the Company, or approximately 9.0% assuming exercise of such Post-Closing Convertible Securities only), and the Joint Actor held an aggregate of 1,850,000 of the Post-Closing Shares and nil of the Post-Closing Convertible Securities (representing approximately 3.4% of the issued and outstanding common shares of the Company).

The Subject Units were acquired in a private placement and not through the facilities of any stock exchange.  The holdings of securities of Global Cannabis by ThreeD and the Joint Actor are managed for investment purposes, and ThreeD and the Joint Actor could increase or decrease their investments in Global Cannabis at any time, or continue to maintain their current investment position, depending on market conditions or any other relevant factor. The aggregate consideration payable for the Subject Units was $200,000, or $0.10 per Subject Unit.

The trade was effected in reliance upon the exemption contained in Section 2.3 of National Instrument 45-106 on the basis that each of ThreeD and the Joint Actor is an “accredited investor” as defined herein.

About ThreeD Capital Inc.

ThreeD Capital Inc. is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources, Artificial Intelligence and Blockchain sectors.

ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services, mentoring and access to the Company’s network in order to earn increases to the Company’s equity stake.

For further information:
Gerry Feldman, CPA, CA
Chief Financial Officer and Corporate Secretary
[email protected]
Phone: 416-606-7655

Tags: , , , , , , , ,
Posted in Featured, ThreeD, ThreeD Capital | Comments Off on ThreeD Capital Inc. $IDK.ca Acquires Securities of Global Cannabis Applications Corp. $APP.ca $PNP.ca $ZC.ca

PyroGenesis $PYR.ca Announces $1.02 Million Sale of 2nd DROSRITE™ Furnace System to North American Automobile Parts Manufacturer $TSLA $DDD $SSYS $PRLB

Posted by AGORACOM-JC at 8:42 AM on Thursday, November 16th, 2017

Pyr header 1

  • Announced today that it has received a purchase order, in the amount of US$ 800,000 (Can$ 1.02 million), for the sale of a second DROSRITE™ Furnace System
  • Purchaser is a North American automobile parts manufacturer

MONTREAL, Nov. 16, 2017 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V:PYR) (OTCQB:PYRNF), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma waste-to-energy systems and plasma torch products, announces today that it has received a purchase order, in the amount of US$ 800,000 (Can$ 1.02 million), for the sale of a second (2nd) DROSRITE™ Furnace System (the “System”) to a North American automobile parts manufacturer (the “Client”).

The system is the second (2nd) commercial System sold to date and represents a re-order from the Client; the name of which remains confidential for competitive reasons. Delivery is scheduled to be in Q2-2018, and the contract calls for a fifty percent (50%) down payment and ten percent (10%) holdback.

PyroGenesis’ DROSRITE™ System is a salt-free, cost-effective, sustainable process for maximizing metal recovery from dross, a waste generated in the metallurgical industry. PyroGenesis’ patented process avoids costly loss of metal while reducing a smelter’s carbon footprint and energy consumption, providing an impressive return on investment.

“With aluminum manufacturers being subjected to increased pressure from regulatory authorities, requiring them to eliminate landfilling of hazardous salt cakes from traditional recovery operations, combined with tight operating margins, PyroGenesis’ DROSRITE™ System is able to (i) increase metal recovery from waste, without producing any hazardous by-products, while (ii) reducing operating costs,” said Mr. Pierre Carabin, Chief Technology Officer of PyroGenesis.

Additionally, as previously announced, PyroGenesis had received an unsolicited offer from a waste management company to be the sole distributor of PyroGenesis’ DROSRITE™ System within the Gulf Cooperation Council (the “GCC”). A successful DROSRITE™ demonstration was conducted at a major aluminum smelter, following which a formal visit took place at PyroGenesis’ facility in Montreal, Canada. Negotiations for the sale of DROSRITE™ Systems are currently underway.

Separately, a potential client from India has engaged PyroGenesis to perform a pilot demonstration at its manufacturer facility. The pilot system is currently being deployed to India for a demonstration scheduled in Q1-2018.

“PyroGenesis has recently hired a dedicated business development professional to address the growing demand for DROSRITE™,” said Massimo Dattilo, VP, Business Development of PyroGenesis. “Given our existing Client’s need for an additional 2 systems; combined with the continuing demand from the Middle East; and the fact that the Company’s demonstration unit is currently in-transit to India, all reflects, we believe, DROSRITE™â€™s success at addressing a serious need within the aluminum industry. The Company is currently targeting primary aluminum smelters in Asia and the Middle East where the market is estimated to be in excess of 1 million tonnes of dross1, as well as tertiary casting producers worldwide, all of which we expect will represent a potential requirement for DROSRITE™ systems numbering in the hundreds of units.”

“We expect DROSRITE™ to be a significant contributor to the operations of our non-additive business segments,” said Mr. P. Peter Pascali, President and CEO of PyroGenesis. “It underscores the success of our strategic plan in targeting high value niche problems in various industries. The fact that we have one of the largest concentrations of plasma expertise, under one roof, gives us the unique advantage of being able to target, and address, these opportunities.”

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc. is the world leader in the design, development, manufacture and commercialization of advanced plasma processes. PyroGenesis provides engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Its core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Its operations are ISO 9001:2008 certified, and have been ISO certified since 1997. PyroGenesis is a publicly-traded Canadian company on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace (Ticker Symbol: PYRNF). For more information, please visit www.pyrogenesis.com

 

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

 

Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTC Markets Group Inc. accepts responsibility for the adequacy or accuracy of this press release.

 

For further information: Rodayna Kafal, VP, Investor Relations and Communications, Phone: (514) 937-0002, E-mail: [email protected] or [email protected]

Tags: , ,
Posted in All Recent Posts, Featured, PyroGenesis Canada Inc. | Comments Off on PyroGenesis $PYR.ca Announces $1.02 Million Sale of 2nd DROSRITE™ Furnace System to North American Automobile Parts Manufacturer $TSLA $DDD $SSYS $PRLB

Tetra Bio-Pharma Inc. $TBP.ca Rx Princeps(TM) Now Available for Patients through Licensed Producer Partner Aphria $APH.ca $AERO $CBDS $CGRW $GBLX

Posted by AGORACOM-JC at 8:23 AM on Thursday, November 16th, 2017

Logo tetrabiopharma rgb web

  • Announced that Rx Princeps™, unique blend of dried medical cannabis used in its PPP001 clinical trials, is now available through licensed producer Aphria Inc.

OTTAWA, ONTARIO–(Nov. 16, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that Rx Princeps™, unique blend of dried medical cannabis used in its PPP001 clinical trials, is now available through licensed producer Aphria Inc. (“Aphria”) under Access to Cannabis for Medical Purposes Regulations (ACMPR).

Based on the most recent ACMPR market data from the Government of Canada, it is estimated that the sales of dried medical cannabis in Canada from April 2017 to March 2018 will be over $188M; Tetra is now entering this lucrative market and plans on progressively grabbing a significant share of it over the next two years. Mr Fortier, CEO of Tetra, stated last week “We are expecting to generate around $1.5 million in sales, in fiscal 2018 in our initial launch. Through our promotion and education efforts in Quebec, New Brunswick and part of Ontario, we estimate that over eight thousand patients will start using Rx Princeps™ under prescription from their doctors over in the next twelve months.”

Rx Princeps™ is a new option for doctors who want to prescribe medical cannabis. Prescribing Rx Princeps™ with the Rx Princeps™ inhalation device enables their patients to optimize the benefits of medical cannabis through the intake of a fixed dose of product, thereby ensuring consistency of treatment with a standardized high-quality product.

Aphria grows and produces medical cannabis under a strict quality management program. Tetra chose Aphria as its partner because their production processes were adopted from the highly restricted and regulated pharmaceutical industry, and go above and beyond cannabis industry regulations mandated by Health Canada. As a result, Aphria’s products are in line with the strict quality standards Tetra is establishing for the medical community and its patients.

200,000 patients are already registered under the ACMPR program and around 1.5 million adults in Canada suffer from chronic pain and are considered non-responders to opioids; medical cannabis could be a new therapeutic choice for those patients but physicians need bioavailability and safety data to prescribe medical cannabis with confidence. According to Health Canada, less than 3,000 physicians actually prescribe cannabis to their patients. Tetra is committed to provide them rigorous safety and bioavailability data. Tetra has begun educating pain clinics and the medical profession across Canada on Rx Princeps™, including its advantages for patients.

In Quebec, Tetra is working closely with Sante Cannabis in order to educate patients and support them in their medical journey with cannabis. Sante Cannabis is the first cannabinoid clinic and medical marijuana resource centre in Quebec.

About Rx Princeps™:

Rx Princeps™ is a unique blend of 3 strains of medical cannabis. Its production has been standardized in order to ensure a lot-to-lot consistent composition in its active ingredients (THC and CBD). Rx Princeps™ is composed of the same medical cannabis blend used to produce PPP001, which has demonstrated its safety in the Phase 1 clinical trial of PPP001. Patients who want to purchase Rx Princeps™ in Canada need a prescription from their physicians and to register with Licensed Producer Aphria.

About Tetra Bio-Pharma:

Tetra Bio-Pharma (TSX VENTURE:TBP)(OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and clinical development. Tetra is focusing on three core business pillars: clinical research, pharmaceutical promotion and retail commercialization of cannabinoid-based products.

More information at: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; the success of the Rx Princeps™ product offering and inhalation device; guidance on expected sales volumes associated with the Rx Princeps™ product offering and inhalation device; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Dr. Anne-Sophie Courtois, DVM
Vice President, Marketing & Communications
(514) 360-8040 Ext. 210
[email protected]
www.tetrabiopharma.com

Tags: , , , , ,
Posted in All Recent Posts, Featured, Medical Marijuana Stocks, Tetra Bio-Pharma Inc. | Comments Off on Tetra Bio-Pharma Inc. $TBP.ca Rx Princeps(TM) Now Available for Patients through Licensed Producer Partner Aphria $APH.ca $AERO $CBDS $CGRW $GBLX

INTERVIEW: Namaste $N.ca Discusses Acquisition of Brazil’s LARGEST #Vaporizer Retailer (AT NO COST) $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 7:59 AM on Wednesday, November 15th, 2017

Nlogo

AGORACOM Founder, George Tsiolis, sat down with Namaste CEO, Sean Dollinger, to produce the most powerful Namaste interview yet.  This is a must watch for anyone invested in the Cannabis / Medical Marijuana space.  The Topics include:

  1. The Company’s latest Brazil acquisition. Adding 10,000 customers, $1M Revenues AT NO COST … and projecting to generate $350,000 in Net Income BEFORE growing top line revenues.
  2. NamasteMD, the pending iPhone App (and Android) that seamlessly connects patients, their medical records, doctors and facial recognition technology to access Medical Marijuana.
  3. Becoming the Amazon of the Vapes & Cannabis Industries.
  4. Doubling Growth every year for the next several years.

There is no other way to say it. Namaste Technologies is the e-commerce powerhouse of this industry … and we know what the technology leader can do to non-tech industry encumbents. Think Amazon, Uber, Airbnb and more.

WATCH

Tags: , , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, Featured, Namaste Technologies Inc. | Comments Off on INTERVIEW: Namaste $N.ca Discusses Acquisition of Brazil’s LARGEST #Vaporizer Retailer (AT NO COST) $AERO $CBDS $CGRW $APH.ca $GBLX

#NSM.ca Northern Sphere Drills an Impressive 13.3 Grams Gold over 10.5 Metres $Wm.ca $FNI.ca

Posted by AGORACOM at 2:24 PM on Tuesday, November 14th, 2017

 

  • Northern Sphere received 1st set of assays for its initial drill program at Scadding in Sudbury
  • Hole 17-03 Intercepted 13.3 Grams Gold over 10.5 Metres in a Chlorite Breccia with visible gold
  • Hole 17-06 encountered approximately 100 metres of mineralized chlorite breccia, intersecting a significant fault structure at 158m, mineralized quartz veining along with apparent mineralized felsics.
  • Eric Sprott holds an Insider Position in the Company
  • Helmed by Legendary Financier Sheldon Inwentash, CPA, CA., LL.D. (Hon)

 

 

Link to Nov 8th Press Release

 

Tags: , , , , ,
Posted in AGORACOM News And Events, All Recent Posts, Featured, Small and Micro-Cap Space | Comments Off on #NSM.ca Northern Sphere Drills an Impressive 13.3 Grams Gold over 10.5 Metres $Wm.ca $FNI.ca

Augusta $AAO.ca Announces Normal Course Issuer Bid For Up To 17,340,061 Common Shares $PHO.ca $DYA.ca $OPS.ca

Posted by AGORACOM-JC at 12:02 PM on Tuesday, November 14th, 2017

 

Augustalarge

  • Intends to commence a normal course issuer bid for up to 17,340,061 common shares,
  • Representing up to 10% of the Company’s public float
  • Purchases will be by way of open market purchases through the facilities of the TSX Venture Exchange
  • Company will pay the market price of the Shares at the time of acquisition

Toronto, Ontario–(November 14, 2017) – Augusta Industries Inc. (TSXV: AAO) (the “Company”) would like to announce its intention to commence a normal course issuer bid (“NCIB”) for up to 17,340,061 common shares (“Shares”), representing up to 10% of the Company’s public float.

Purchases will be by way of open market purchases through the facilities of the TSX Venture Exchange (the “Exchange”) and the Company will pay the market price of the Shares at the time of acquisition. The Company will conduct the NCIB through TD Securities. All Shares purchased by the Company will be subsequently cancelled.

The Company has received approval from the Exchange to commence its NCIB on November 20, 2017. The bid will end on November 19, 2018 or earlier if the number of Shares sought in the NCIB has been obtained. The Company reserves the right to terminate the bid earlier if it determines such action to be appropriate. Although the Company intends to purchase Shares under its NCIB, there can be no assurance that any such purchases will be completed.

The Company believes that the purchase of the Shares will increase the proportionate interest of, and be advantageous to, all remaining security holders. The normal course purchases will also afford an increased degree of liquidity in the market.

About the Corporation

Through its wholly owned subsidiaries, Marcon International Inc. (“Marcon”) and Fox-Tek Canada Inc. (“Fox-Tek”), the Company provides a variety of services and products to a number of clients.

Marcon is an industrial supply contractor servicing the energy sector and a number of US Government entities. Marcon’s principal business is the sale and distribution of industrial parts and equipment.

Fox-Tek provides world leading solutions to various sectors including the oil and gas industry. With non-intrusive technologies including fiber-optic sensors and electric field mapping systems, Fox-Tek is able to accurately measure changes that could negatively impact our client’s operations.

Corporation Contact:

Allen Lone, President and C.E.O.
Tel: 905.275.8111, Ext. 226
Email: [email protected]

The TSX Venture Exchange has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

This press release contains forward-looking statements based on assumptions, uncertainties and management’s best estimates of future events. Actual results may differ materially from those currently anticipated. Investors are cautioned that such forward-looking statements involve risks and uncertainties. Important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements are detailed from time to time in the Company‘s periodic reports filed with the Ontario Securities Commission and other regulatory authorities. The Company has no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Tags: , ,
Posted in All Recent Posts, Augusta Industries, Featured | Comments Off on Augusta $AAO.ca Announces Normal Course Issuer Bid For Up To 17,340,061 Common Shares $PHO.ca $DYA.ca $OPS.ca

Wallbridge $WM.ca announces a custom milling contract with Monarques Gold $MQR.ca for 35,000-tonne bulk sample from Fenelon #Gold property

Posted by AGORACOM-JC at 9:34 AM on Tuesday, November 14th, 2017

Monarquesgold hub large

  • Monarques will process the 35,000-tonne bulk sample ore from the Fenelon Gold property, located 75 km west-northwest of Matagami, Quebec, at its Camflo mill.

TORONTO, Nov. 14, 2017 – Wallbridge Mining Company Limited (TSX:WM, FWB: WC7) (“Wallbridge“) is pleased to announce that progress toward mining of a bulk sample at its Fenelon Gold property has taken a significant step forward with the signing of a custom milling contract with Monarques Gold Corporation (“Monarques”) (TSX.V:MQR) (FRANKFURT:MR7).

Monarques will process the 35,000-tonne bulk sample ore from the Fenelon Gold property, located 75 km west-northwest of Matagami, Quebec, at its Camflo mill.

“The signing of this toll milling contract is a major milestone in our plans for an underground bulk sample to assess the nature of high-grade gold mineralization and to drill for expansion of the resource at the Fenelon Gold property,” said Marz Kord, Wallbridge President and CEO, “Importantly, the Camflo mill is familiar with the characteristics of processing Fenelon Gold ore. This is the same mill which processed previous bulk samples from Fenelon Gold in 2001 and 2004 with recoveries in excess of 97% at head grades of over 10 grams per tonne.”

The Qualified Person responsible for this press release is Marz Kord, P.Eng., M.Sc., MBA, President & CEO for Wallbridge Mining Company Limited.

About Wallbridge Mining

Wallbridge is establishing a pipeline of projects that will support sustainable production and revenue as well as organic growth through exploration and scalability.

Wallbridge is currently preparing to develop its 100%-owned high-grade Fenelon Gold Property in Quebec with ongoing exploration and a bulk sample targeted to start in 2017. Wallbridge is also in discussions regarding several other advanced stage projects which could become the Company’s next mines.  These discussions benefit from the operating capabilities Wallbridge demonstrated by safely and efficiently mining the Broken Hammer deposit in Sudbury, which was completed in October 2015.  Wallbridge is also continuing partner-funded exploration on its large portfolio of nickel, copper, and PGM projects in Sudbury, Ontario, with a focus on its high-grade Parkin project.

Wallbridge also has exposure to active exploration for copper and gold in Jamaica and British Columbia through its 12.7% ownership of Carube Copper Corp. (CUC:TSX-V, formerly Miocene Resources Limited).

This press release may contain forward-looking statements (including “forward-looking information” within the meaning of applicable Canadian securities legislation and “forward-looking statements” within the meaning of the US Private Securities Litigation Reform Act of 1995) relating to, among other things, the operations of Wallbridge and the environment in which it operates. Generally, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Wallbridge has relied on a number of assumptions and estimates in making such forward-looking statements, including, without limitation, the costs associated with the development and operation of its properties. Such assumptions and estimates are made in light of the trends and conditions that are considered to be relevant and reasonable based on information available and the circumstances existing at this time. A number of risk factors may cause actual results, level of activity, performance or outcomes of such exploration and/or mine development to be materially different from those expressed or implied by such forward-looking statements including, without limitation, whether such discoveries will result in commercially viable quantities of such mineralized materials, the possibility of changes to project parameters as plans continue to be refined, the ability to execute planned exploration and future drilling programs, the need for additional funding to continue exploration and development efforts, changes in general economic, market and business conditions, and those other risks set forth in Wallbridge’s most recent annual information form under the heading “Risk Factors” and in its other public filings. Forward-looking statements are not guarantees of future performance and such information is inherently subject to known and unknown risks, uncertainties and other factors that are difficult to predict and may be beyond the control of Wallbridge. Although Wallbridge has attempted to identify important risks and factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors and risks that cause actions, events or results not to be as anticipated, estimated or intended. Consequently, undue reliance should not be placed on such forward-looking statements. In addition, all forward-looking statements in this press release are given as of the date hereof.

Wallbridge disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, save and except as may be required by applicable securities laws. The forward-looking statements contained herein are expressly qualified by this disclaimer.

SOURCE Wallbridge Mining Company Limited

View original content with multimedia: http://www.newswire.ca/en/releases/archive/November2017/14/c1153.html

Please visit the Company’s website at www.wallbridgemining.com or contact: Wallbridge Mining Company Limited, Joshua Bailey, P.Geo., M.Sc., MBA, Vice President Exploration, Tel: (705) 682-9297 ext. 240, Email: [email protected]; David Ellis, Investor Relations, Tel: (416) 704-0937, Email: [email protected] CNW Group 2017

Tags: , , , ,
Posted in Featured, Monarques Gold | Comments Off on Wallbridge $WM.ca announces a custom milling contract with Monarques Gold $MQR.ca for 35,000-tonne bulk sample from Fenelon #Gold property

Namaste $N.ca Expands Brazilian Market and Acquires Leading Vaporizer Retailer $ATT.ca $ABCN.ca $ACG.ca $ACB

Posted by AGORACOM-JC at 9:30 AM on Tuesday, November 14th, 2017

Nlogo

  • Acquired the domain and customer database of Brazil’s largest vaporizer retailer, vaptvupt.lojaintegrada.com.br
  • Acquisition of VapeBr is accretive in nature and is expected to add over CAD $1M in additional annual revenue to Namaste’s current revenue stream

VANCOUVER, British Columbia, Nov. 14, 2017 – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRANKFURT:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that it has acquired the domain and customer database of Brazil’s largest vaporizer retailer, vaptvupt.lojaintegrada.com.br (“VapeBr”), in consideration of signing an exclusive services agreement for fulfillment (the “Agreement”) for Namaste’s Brazilian operations.  The acquisition of VapeBr is accretive in nature and is expected to add over CAD $1M in additional annual revenue to Namaste’s current revenue stream.

Under the terms of the Agreement, Namaste has acquired the VapeBr domain and will therefore inherit all future associated revenue.

VapeBr management has agreed to provide the following under the Agreement:

  • Inventory management
  • Order processing
  • Local support
  • Warranty/Return Processing

As a result of this transaction, Namaste plans to greatly expand the VapeBr product offering, as it sees very strong growth potential in the Brazilian market. The acquisition of the VapeBr e-commerce platform is not only expected to have an immediate impact on Namaste’s revenue, but it is also expected to add over 10,000 additional customers to Namaste’s growing global database of medical cannabis users. Through the integration of VapeBr onto Namaste’s proven e-commerce platform, Namaste is confident it can substantially grow this already impressive customer base. This Agreement further validates Namaste’s ability to consolidate industry competitors and expand its operations abroad.

Additionally, Namaste is pleased to announce that the NamasteMD smartphone app has been submitted to the Apple Store, is awaiting approval, and is expected to soon be available on both IOS and Android devices. NamasteMD is a revolutionary telemedicine application which has been designed to connect patients with doctors and nurse practitioners, in an attempt to facilitate a seamless process for obtaining medical documents under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”) program. This state of the art application incorporates facial recognition algorithms, and is the first of its kind to feature exclusive age and identity verification technology. Namaste plans on utilizing this technology on the NamasteMD platform to distribute medicinal cannabis through its wholly owned subsidiary, Cannmart Inc.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments:  “I am extremely proud of our team for building an e-commerce platform that is being actively solicited by our direct competitors to work collaboratively. Based on this agreement, we expect further opportunities to present themselves for Namaste to work with companies looking to divest their businesses, and believe such arrangements are a win-win situation for all parties involved. We are extremely excited that our efforts are not only being noticed but rewarded with arrangements as such. Namaste welcomes these opportunities and anticipates these trends to continue as Namaste steals market share on a global scale. This transaction further confirms the value we have created with regards to the products and services we provide, and our ability to leverage our database moving forward.

As our e-commerce platform evolves, we are confident our decision to implement cutting edge age and identity verification technology ahead of our competition will be instrumental in allowing us to become industry leaders. We believe these innovative initiatives not only demonstrate our commitment to the industry, but also provide an ideal solution to ensure the safe and responsible distribution of recreational cannabis on both a provincial and federal level.”

About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, US, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
+1 (786) 389 9771
Email: [email protected]

Further information on the Company and its products can be accessed through the links below:
www.namastetechnologies.com
www.namastevaporizers.com
www.namastevaporizers.co.uk
www.everyonedoesit.com
www.everyonedoesit.co.uk

FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Tags: , , , , ,
Posted in All Recent Posts, Featured, Namaste Technologies Inc. | Comments Off on Namaste $N.ca Expands Brazilian Market and Acquires Leading Vaporizer Retailer $ATT.ca $ABCN.ca $ACG.ca $ACB

« Older Entries
Newer Entries »